Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B C Liu

Showing results (81-90 of 115) with videos related to

Pageof 12
Sort By:
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 29, 2021
[Treatment status of tyrosine kinase inhibitors in Chinese patients with chronic myeloid leukemia in 2020]H F Wang, Y L Zhang, X L Liu, et al.
Zhonghua Yi Xue Za Zhi|May 17, 2023
[Diagnostic value of multiparametric MRI-based models in the assessment of extra-prostatic extension of prostate cancer]B C Liu, H Y Wang, Z Dong, et al.
Zhonghua Nei Ke Za Zhi|July 29, 2024
[Clinical analysis of seven cases of primary hyperoxaluria type 1]Z L Li, B Wang, F M Wang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|June 9, 2022
[Clinical and genetic characteristics of patients with newly diagnosed acute promyelocytic leukemia: a single-center retrospective of 790 cases]M Z Yang, L Li, H Wei, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|April 20, 2020
[Analysis of risk factors for necrosis of femoral head after internal fixation surgery in young and mid-aged patients with femoral neck fracture]B C Liu, C Sun, Y Xing, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 28, 2023
[Observational study of chronic myeloid leukemia Chinese patients who discontinued tyrosine kinase inhibitors in the real-world]H F Zhao, Y F Yang, B C Liu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|October 27, 2025
[Identify the factors associated with treatment-free remission outcomes after imatinib discontinuation in children and adolescent patients with chronic myeloid leukemia]H F Zhao, Q Jiang, W M Li, et al.
Zhonghua Yi Xue Za Zhi|December 1, 2020
[Development of a hyperkalemia risk assessment model for patients with chronic kidney disease]C L Mei, X N Chen, C M Hao, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|November 2, 2016
[Application of imatinib in BCR- ABL positive acute lymphoblastic leukemia treatment in the real world]Y L Wan, Y Wang, B C Liu, et al.
The Review of Scientific Instruments|October 5, 2013
Note: A new angle-resolved proton energy spectrometerY Zheng, L N Su, M Liu, et al.
Pageof 12

Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 29, 2021
[Treatment status of tyrosine kinase inhibitors in Chinese patients with chronic myeloid leukemia in 2020]H F Wang, Y L Zhang, X L Liu, et al.
Zhonghua Yi Xue Za Zhi|May 17, 2023
[Diagnostic value of multiparametric MRI-based models in the assessment of extra-prostatic extension of prostate cancer]B C Liu, H Y Wang, Z Dong, et al.
Zhonghua Nei Ke Za Zhi|July 29, 2024
[Clinical analysis of seven cases of primary hyperoxaluria type 1]Z L Li, B Wang, F M Wang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|June 9, 2022
[Clinical and genetic characteristics of patients with newly diagnosed acute promyelocytic leukemia: a single-center retrospective of 790 cases]M Z Yang, L Li, H Wei, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|April 20, 2020
[Analysis of risk factors for necrosis of femoral head after internal fixation surgery in young and mid-aged patients with femoral neck fracture]B C Liu, C Sun, Y Xing, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 28, 2023
[Observational study of chronic myeloid leukemia Chinese patients who discontinued tyrosine kinase inhibitors in the real-world]H F Zhao, Y F Yang, B C Liu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|October 27, 2025
[Identify the factors associated with treatment-free remission outcomes after imatinib discontinuation in children and adolescent patients with chronic myeloid leukemia]H F Zhao, Q Jiang, W M Li, et al.
Zhonghua Yi Xue Za Zhi|December 1, 2020
[Development of a hyperkalemia risk assessment model for patients with chronic kidney disease]C L Mei, X N Chen, C M Hao, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|November 2, 2016
[Application of imatinib in BCR- ABL positive acute lymphoblastic leukemia treatment in the real world]Y L Wan, Y Wang, B C Liu, et al.
The Review of Scientific Instruments|October 5, 2013
Note: A new angle-resolved proton energy spectrometerY Zheng, L N Su, M Liu, et al.
Pageof 12